Cargando…

Multiple Pathogens Contribute to Human Immunodeficiency Virus-Related Sepsis in Addition to Mycobacterium tuberculosis: A Prospective Cohort in Tanzania

BACKGROUND: Mortality from tuberculosis (TB) sepsis is common among patients living with human immunodeficiency virus (PLHIV). We aimed to detect M. tuberculosis (MTB) and additional sepsis etiologies, and mortality determinants in PLHIV. METHODS: This prospective cohort study consented and followed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsere, Donatus Bonphace, Shirima, Gabriel Mkilema, Grundy, Brian S., Heysell, Scott K., Mpagama, Stellah G., Mziray, Shabani Ramadhani, Mbelele, Peter M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582297/ https://www.ncbi.nlm.nih.gov/pubmed/36260441 http://dx.doi.org/10.4103/ijmy.ijmy_80_22

Ejemplares similares

Whole-genome sequencing of SARS-CoV-2 isolates from symptomatic and asymptomatic individuals in Tanzania
por: Mziray, Shabani Ramadhani, et al.
Publicado: (2023)

Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion
por: Mpagama, Stellah G., et al.
Publicado: (2020)

Improved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong’oto infectious diseases hospital in Tanzania
por: Mbelele, Peter M., et al.
Publicado: (2017)

Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation
por: Mpagama, Stellah G., et al.
Publicado: (2019)

Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania
por: Mbelele, Peter M., et al.
Publicado: (2022)

Pharmacodynamic Biomarkers for Quantifying the Mycobacterial Effect of High Doses of Rifampin in Patients with Rifampin-susceptible Pulmonary Tuberculosis
por: Said, Bibie N, et al.
Publicado: (2021)

Diagnostic Opportunities for Optimizing Management of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania
por: Mpagama, Stellah G
Publicado: (2018)

Determination of plasma concentrations of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in Tanzania
por: Ebers, Andrew, et al.
Publicado: (2017)

Decision Analytic Modeling for Global Clinical Trial Planning: A Case for HIV-Positive Patients at High Risk for Mycobacterium tuberculosis Sepsis in Uganda
por: Keim-Malpass, Jessica, et al.
Publicado: (2023)

Clinical-demographic markers for improving diabetes mellitus diagnosis in people with tuberculosis in Tanzania
por: Byashalira, Kenneth Cleophace, et al.
Publicado: (2022)

Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania
por: Katale, Bugwesa Z., et al.
Publicado: (2020)

TB or not TB? Definitive determination of species within the M ycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug‐resistant tuberculosis
por: Mbelele, Peter M., et al.
Publicado: (2021)

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
por: Mpagama, Stellah G, et al.
Publicado: (2013)

Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania
por: Mbelele, Peter M., et al.
Publicado: (2021)

Meta-Narrative Review of Molecular Methods for Diagnosis and Monitoring of Multidrug-Resistant Tuberculosis Treatment in Adults
por: Mbelele, Peter M., et al.
Publicado: (2018)

Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania
por: Mpagama, Stellah G., et al.
Publicado: (2023)

Epidemiology of leptospirosis in Tanzania: A review of the current status, serogroup diversity and reservoirs
por: Motto, Shabani Kiyabo, et al.
Publicado: (2021)

Comparison of Overnight Pooled and Standard Sputum Collection Method for Patients with Suspected Pulmonary Tuberculosis in Northern Tanzania
por: Mpagama, Stellah G., et al.
Publicado: (2012)

Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania
por: Mohamed, Sagal, et al.
Publicado: (2021)

Diagnosis and Interim Treatment Outcomes from the First Cohort of Multidrug-Resistant Tuberculosis Patients in Tanzania
por: Mpagama, Stellah G., et al.
Publicado: (2013)

Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania
por: Juma, Saumu Pazia, et al.
Publicado: (2019)

Early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial
por: Said, Bibie, et al.
Publicado: (2022)

Gridlock from Diagnosis to Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania: Illuminating Potential Factors for Possible Intervention
por: Liyoyo, Alphonce A, et al.
Publicado: (2017)

Protocol for establishing an Adaptive Diseases control Expert Programme in Tanzania (ADEPT) for integrating care of communicable and non-communicable diseases using tuberculosis and diabetes as a case study
por: Mpagama, Stellah G, et al.
Publicado: (2021)

Evaluation of cytokines in peripheral blood mononuclear cell supernatants for the diagnosis of tuberculosis
por: Sariko, Margaretha, et al.
Publicado: (2018)

Insights into the genetic diversity of Mycobacterium tuberculosis in Tanzania
por: Rutaihwa, Liliana K., et al.
Publicado: (2019)

Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis
por: Sariko, Margaretha, et al.
Publicado: (2017)

Enteropathogen spectrum and effect on antimycobacterial pharmacokinetics among children with tuberculosis in rural Tanzania: a prospective cohort study
por: Van Aartsen, Daniel, et al.
Publicado: (2022)

The Status and Risk Factors of Brucellosis in Smallholder Dairy Cattle in Selected Regions of Tanzania
por: Mengele, Isaac Joseph, et al.
Publicado: (2023)

Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania
por: Mziray, Shabani Ramadhani, et al.
Publicado: (2020)

Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania
por: Maya, Togolani Godfrey, et al.
Publicado: (2022)

Seroepidemiology of Leptospira serovar Hardjo and associated risk factors in smallholder dairy cattle in Tanzania
por: Motto, Shabani Kiyabo, et al.
Publicado: (2023)

Seroprevalence and Risk Factors for Q fever (Coxiella burnetii) Exposure in Smallholder Dairy Cattle in Tanzania
por: Bwatota, Shedrack Festo, et al.
Publicado: (2022)

Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis
por: Sidamo, Temesgen, et al.
Publicado: (2022)

Improvement in Plasma Drug Activity during the Early Treatment Interval among Tanzanian Patients with Multidrug-Resistant Tuberculosis
por: Ndusilo, Norah D., et al.
Publicado: (2015)

High burden of tuberculosis infection and disease among people receiving medication-assisted treatment for substance use disorder in Tanzania
por: Minja, Lilian Tina, et al.
Publicado: (2021)

Implementing Innovative Approaches to Improve Health Care Delivery Systems for Integrating Communicable and Non-Communicable Diseases Using Tuberculosis and Diabetes as a Model in Tanzania
por: Mpagama, Stellah G., et al.
Publicado: (2023)

Coinfection of COVID-19 and Tuberculosis in Uganda
por: Nuwagira, Edwin, et al.
Publicado: (2023)

Experiences and perceptions of participants on the pathway towards clinical management of dual tuberculosis and diabetes mellitus in Tanzania
por: Chamba, Nyasatu G., et al.
Publicado: (2022)

Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis
por: Operario, Darwin J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c73tb1fpq7kmikl1o6cdfad7fh